ea0089c37 | Clinical – Surgery/Applied Pathology | NANETS2022
C. Borbon, MD Luis
, G. Tran, MD Catherine
, K. Sherman, MD Scott
, Hien Ear, PhD Po
, Chandrasekharan, MD Chandrikha
, M. Bellizzi, MD Andrew
, S. Dillon, MD Joseph
, M. O'Dorisio, MD Thomas
, R. Howe, MD James
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are aggressive tumors with poor survival outcomes for which medical management is usually recommended. This study sought to evaluate outcomes of surgically treated G3 GEP-NEN patients.Methods: A single-institutional prospective NEN database was reviewed. Patients with G3 GEP-NENs based on World Health Organization (WHO) 2019 definitions included well-differentiated neur...